SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of EUR 704.33 million. The enterprise value is 610.64 million.
| Market Cap | 704.33M |
| Enterprise Value | 610.64M |
Important Dates
The next estimated earnings date is Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 43.39M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +3.43% |
| Shares Change (QoQ) | +0.94% |
| Owned by Insiders (%) | 3.04% |
| Owned by Institutions (%) | 93.05% |
| Float | 39.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.27 |
| PB Ratio | 4.80 |
| P/TBV Ratio | 4.80 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.93 |
| EV / Sales | 3.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -67.48 |
Financial Position
The company has a current ratio of 7.97, with a Debt / Equity ratio of 0.21.
| Current Ratio | 7.97 |
| Quick Ratio | 6.53 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.47 |
| Interest Coverage | -9.09 |
Financial Efficiency
Return on equity (ROE) is -12.91% and return on invested capital (ROIC) is -7.69%.
| Return on Equity (ROE) | -12.91% |
| Return on Assets (ROA) | -6.87% |
| Return on Invested Capital (ROIC) | -7.69% |
| Return on Capital Employed (ROCE) | -12.20% |
| Revenue Per Employee | 472,741 |
| Profits Per Employee | -53,128 |
| Employee Count | 349 |
| Asset Turnover | 0.84 |
| Inventory Turnover | 1.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.57% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +11.57% |
| 50-Day Moving Average | 13.32 |
| 200-Day Moving Average | 13.22 |
| Relative Strength Index (RSI) | 78.20 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.71 |
Income Statement
In the last 12 months, SI-BONE had revenue of EUR 164.99 million and -18.54 million in losses. Loss per share was -0.44.
| Revenue | 164.99M |
| Gross Profit | 131.36M |
| Operating Income | -21.62M |
| Pretax Income | -18.54M |
| Net Income | -18.54M |
| EBITDA | -17.06M |
| EBIT | -21.62M |
| Loss Per Share | -0.44 |
Balance Sheet
The company has 124.22 million in cash and 31.40 million in debt, giving a net cash position of 92.82 million.
| Cash & Cash Equivalents | 124.22M |
| Total Debt | 31.40M |
| Net Cash | 92.82M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 146.70M |
| Book Value Per Share | 3.39 |
| Working Capital | 157.11M |
Cash Flow
In the last 12 months, operating cash flow was -1.04 million and capital expenditures -8.00 million, giving a free cash flow of -9.05 million.
| Operating Cash Flow | -1.04M |
| Capital Expenditures | -8.00M |
| Free Cash Flow | -9.05M |
| FCF Per Share | n/a |
Margins
Gross margin is 79.62%, with operating and profit margins of -13.10% and -11.24%.
| Gross Margin | 79.62% |
| Operating Margin | -13.10% |
| Pretax Margin | -11.24% |
| Profit Margin | -11.24% |
| EBITDA Margin | -10.34% |
| EBIT Margin | -13.10% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.43% |
| Shareholder Yield | -3.43% |
| Earnings Yield | -2.63% |
| FCF Yield | -1.28% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.12 and a Piotroski F-Score of 4.
| Altman Z-Score | 5.12 |
| Piotroski F-Score | 4 |